About the Authors
- Maria Sabater-Lleal
-
* E-mail: maria.sabater.lleal@ki.se
Affiliation Atherosclerosis Research Unit, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
- Anders Mälarstig
-
Affiliation Pfizer Worldwide Research and Development, Cambridge, United Kingdom
- Lasse Folkersen
-
Current address: PharmakoGenetics department, Novo Nordisk A/S, Bagsvaerd, Denmark
Affiliation Atherosclerosis Research Unit, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
- María Soler Artigas
-
Affiliations Genetic Epidemiology Group, Department of Health Sciences, University of Leicester, Leicester, United Kingdom, National Institute for Health Research, Leicester Respiratory Biomedical Research Unit, Glenfield Hospital, Leicester, United Kingdom
- Damiano Baldassarre
-
Affiliations Dipartimento di Scienze Farmacologiche e Biomolecolari, Università di Milano, Milan, Italy, Centro Cardiologico Monzino, Istituto di Ricovero e Cura a Cattere Scientifico, Milan, Italy
- Maryam Kavousi
-
Affiliation Department of Epidemiology, Erasmus Medical Center - University Medical Center Rotterdam, Rotterdam, the Netherlands
- Peter Almgren
-
Affiliation Department of Clinical Sciences, Lunds University, Malmö, Sweden
- Fabrizio Veglia
-
Affiliation Centro Cardiologico Monzino, Istituto di Ricovero e Cura a Cattere Scientifico, Milan, Italy
- Guy Brusselle
-
Affiliations Department of Epidemiology, Erasmus Medical Center - University Medical Center Rotterdam, Rotterdam, the Netherlands, Department of Internal Medicine, Erasmus Medical Center - University Medical Center Rotterdam, Rotterdam, the Netherlands, Inspectorate for Health Care, The Hague, the Netherlands
- Albert Hofman
-
Affiliation Department of Epidemiology, Erasmus Medical Center - University Medical Center Rotterdam, Rotterdam, the Netherlands
- Gunnar Engström
-
Affiliation Department of Clinical Sciences, Lunds University, Malmö, Sweden
- Oscar H. Franco
-
Affiliation Department of Epidemiology, Erasmus Medical Center - University Medical Center Rotterdam, Rotterdam, the Netherlands
- Olle Melander
-
Affiliations Department of Clinical Sciences, Lunds University, Malmö, Sweden, Department of Internal Medicine, Skåne University Hospital, Malmö, Sweden
- Gabrielle Paulsson-Berne
-
Affiliation Cardiovascular Research Unit, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
- Hugh Watkins
-
Affiliation Department of Cardiovascular Medicine and the Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom
- Per Eriksson
-
Affiliation Atherosclerosis Research Unit, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
- Steve E. Humphries
-
Affiliation Center for Cardiovascular Genetics, Institute of Cardiovascular Science, University College London, London, United Kingdom
- Elena Tremoli
-
Affiliations Dipartimento di Scienze Farmacologiche e Biomolecolari, Università di Milano, Milan, Italy, Centro Cardiologico Monzino, Istituto di Ricovero e Cura a Cattere Scientifico, Milan, Italy
- Ulf de Faire
-
Affiliation Division of Cardiovascular Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
- Martin D. Tobin
-
Affiliations Genetic Epidemiology Group, Department of Health Sciences, University of Leicester, Leicester, United Kingdom, National Institute for Health Research, Leicester Respiratory Biomedical Research Unit, Glenfield Hospital, Leicester, United Kingdom
- Anders Hamsten
-
Affiliation Atherosclerosis Research Unit, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
Competing Interests
With regards to conflicts of interest, the authors have the following interests. Anders Mälarstig is employed by Pfizer Worldwide Research and Development and holds Pfizer stocks and options. Dr. Engström has disclosed being formerly employed by AstraZeneca R&D. Dr. Folkersen is currently employed at Novo Nordisk A/S, Denmark although all his contributions in this manuscript were done when employed at Karolinska Institutet. There are no patents, products in development or marketed products to declare. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.
Author Contributions
Conceived and designed the experiments: MS-L AM MSA MDT A. Hamsten. Analyzed the data: MS-L LF MSA DB MK PA FV. Contributed reagents/materials/analysis tools: GB AH GE OHF OM GPB HW PE SEH ET UdF. Contributed to the writing of the manuscript: MS-L AM MSA DB GE SEH MDT A. Hamsten. Performed statistical analyses: A. Hofman.